Novavax (NVAX) has recently seen a decrease in stock value, dropping after announcing Q4 results that missed revenue expectations. The company ...

FDA nominee Marty Makary pledges to review the cancellation of a key flu vaccine meeting, addressing concerns over ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...